For R&D use only.

NVP-LDE225

  • Catalog NO.:A25438
  • CAS No. : 956697-53-3
  • Molecular Formula:C26H26F3N3O3
  • Molecular Weight: 485.50
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS
HPLC/GC NMR

Product Details

CAS Number 956697-53-3 Appearance
Catalog Number A25438 MDL Number MFCD16038928
Molecular Formula C26H26F3N3O3 Molecular Weight 485.50
Boiling Point 544.516°C at 760 mmHg Melting Point
Flash Point Density
Synonyms LDE-225;Erismodegib;rel-N-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide;LDE225
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements H302-H315-H319-H335 Class
Precautionary Statements P261-P305+P351+P338 Packing Group

Description

Sonidegib, also known as, erismodegib, LDE225, NVP-LDE225, is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity. Erismodegib selectively binds to the Hedgehog (Hh)-ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway and, so, the inhibition of tumor cells in which this pathway is abnormally activated. It was approved by the FDA for treating basal cell carcinoma in July 2015.

Related Products

My Tracks: NVP-LDE225
Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

NVP-LDE225
LDE-225;Erismodegib;rel-N-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide;LDE225